ArticleCurrent cancer drug targets2025

Comprehensive Pan-cancer Analysis of CMPK2 as Biomarker and Prognostic Indicator for Immunotherapy.

Jingyuan Luo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.